Evidence check: Testosteron Test in the context of Darmgesundheit

The evidence for testosterone testing in the context of gut health is currently weak. While preclinical and mechanistic studies suggest bidirectional crosstalk between the gut microbiome and testosterone – for example, via inflammatory mediators like IL-1B or microbial modulation of steroid metabolism – there are no high-quality human trials demonstrating that measuring testosterone levels provides actionable insights for gut health management. The evidence grade is best described as 'mechanistic' or 'unclear'. Testosterone testing is clinically indicated for diagnosing hypogonadism or monitoring hormone therapy, not for assessing gut function. Direct-to-consumer tests often overstate such connections. Safety note: Unsupervised hormone testing may lead to unnecessary supplementation or anxiety. Consumers should rely on evidence-based gut health markers (e.g., stool calprotectin, microbiome diversity) rather than testosterone levels.